Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Both MCUL and HLRCC are caused by a heterozygous mutation in the fumarate hydratase gene.
|
29527031 |
2019 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Eleven of the 372 patients with renal cancer were identified to carried pathogenic FH variants associated with HLRCC.
|
31444830 |
2020 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The genetic basis for the hereditary leiomyomatosis and renal cell cancer syndrome is germ-line inactivating mutation in the gene for the Krebs/tricarboxylic acid cycle enzyme, fumarate hydratase (FH), the enzyme that converts fumarate to malate.
|
19276158 |
2009 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the <i>FH</i> gene have been associated with fumarate hydratase deficiency (FHD), hereditary leiomyomatosis and renal cell cancer (HLRCC), and other diseases.
|
31522598 |
2020 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Ten of the 13 lesions from patients with HLRCC syndrome showed negative FH staining.
|
27097334 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Inactivating germline mutations in FH cause hereditary leiomyomatosis and renal cell cancer (HLRCC), a cancer syndrome characterised by accumulation of fumarate.
|
30190474 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC).
|
17908262 |
2008 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The hereditary cancer syndromes hereditary leiomyomatosis and renal cell cancer (HLRCC) and succinate dehydrogenase-related hereditary paraganglioma and pheochromocytoma (SDH PGL/PCC) are linked to germline loss-of-function mutations in genes encoding the Krebs cycle enzymes fumarate hydratase and succinate dehydrogenase, thus leading to elevated levels of fumarate and succinate, respectively<sup>1-3</sup>.
|
30013182 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer.
|
27580029 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Similarly, identification of mutations in the fumarate hydratase (FH) gene that lead to a syndrome called hereditary leiomyomatosis and renal cell carcinoma (HLRCC) will impact screening and treatment of women with uterine leiomyomas.
|
16582132 |
2006 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations of FH, the gene that encodes for the tricarboxylic acid TCA (TCA) cycle enzyme fumarate hydratase, are associated with an inherited form of cancer referred to as Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC).
|
21695080 |
2011 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is caused by autosomal dominant germline mutations in the fumarate hydratase (FH) gene and is characterized by cutaneous leiomyomas, uterine leiomyomas and aggressive renal malignancies.
|
29423582 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Early studies of two familial cancer syndromes, the multiple cutaneous and uterine leiomyomatosis (MCUL1), and the hereditary leiomyomatosis and renal cell cancer (HLRCC), implicated FH, a gene on chromosome 1q43 encoding the tricarboxylic acid cycle fumarate hydratase enzyme.
|
23555580 |
2013 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
This method enables the facile measurement of fumarate hydratase activity in cell and tissue samples, and can be used to detect disruptions in metabolism that underlie the genetic cancer syndrome hereditary leiomyomatosis and renal cell cancer (HLRCC).
|
31155064 |
2019 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
The overall sensitivity and specificity of absent FH expression in leiomyomas for detection of patients with HLRCC were 70.0% and 97.6%, respectively.
|
28288038 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SDH mutations establish a hypermethylator phenotype in paraganglioma.
|
23707781 |
2013 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH).
|
26983443 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency.
|
8200987 |
1994 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome).
|
21051878 |
2010 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
|
11865300 |
2002 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous germline mutations in the FH gene predispose to an aggressive autosomal dominant inherited early-onset kidney cancer syndrome: hereditary leiomyomatosis and renal cell cancer (HLRCC).
|
28747166 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
FH/2SC immunohistochemistry was informative as all hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas were either FH- or 2SC+.
|
29410489 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
|
20618355 |
2011 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Patients with hereditary leiomyomatosis and renal cell carcinoma (HLRCC) resulting from fumarate hydratase (FH) mutations may present with skin, uterine, and renal tumors, with each having unique pathologic features.
|
28171700 |
2017 |